Reckitt Benckiser Group plc (OTCMKTS:RBGLY - Get Free Report)'s share price crossed above its 200-day moving average during trading on Thursday . The stock has a 200-day moving average of $11.86 and traded as high as $12.03. Reckitt Benckiser Group shares last traded at $12.03, with a volume of 418,019 shares.
Analyst Ratings Changes
Several research firms have weighed in on RBGLY. Citigroup raised Reckitt Benckiser Group to a "strong-buy" rating in a research note on Tuesday, October 1st. Sanford C. Bernstein downgraded shares of Reckitt Benckiser Group from a "strong-buy" rating to a "hold" rating in a research report on Monday, November 4th. Hsbc Global Res raised shares of Reckitt Benckiser Group from a "hold" rating to a "strong-buy" rating in a research note on Wednesday, December 11th. Barclays raised shares of Reckitt Benckiser Group to a "strong-buy" rating in a research note on Friday, October 4th. Finally, HSBC raised shares of Reckitt Benckiser Group from a "hold" rating to a "buy" rating in a research report on Wednesday, December 11th. Two investment analysts have rated the stock with a hold rating, one has assigned a buy rating and four have given a strong buy rating to the company. Based on data from MarketBeat, the company presently has a consensus rating of "Buy".
Check Out Our Latest Stock Report on RBGLY
Reckitt Benckiser Group Price Performance
The company has a 50-day moving average of $12.15 and a 200-day moving average of $11.86. The company has a debt-to-equity ratio of 0.97, a current ratio of 0.69 and a quick ratio of 0.47.
About Reckitt Benckiser Group
(
Get Free Report)
Reckitt Benckiser Group plc manufactures and sells health, hygiene, and nutrition products worldwide. It offers acne treatment creams, facial washes, and cleansing pads; germ protection products; condoms; heartburn and indigestion solutions; joints health products; chest congestion, cough, and sinus remedies; brain health products; migraine-headaches and rheumatic pain products; sore throat medications; and hair removal products under the Airborne, Clearasil, Dettol, Durex, Gaviscon, Move Free, Neuriva, Nurofen, Mucinex, Strepsils, and Veet brands.
Recommended Stories
Before you consider Reckitt Benckiser Group, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Reckitt Benckiser Group wasn't on the list.
While Reckitt Benckiser Group currently has a "Buy" rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
MarketBeat's analysts have just released their top five short plays for January 2025. Learn which stocks have the most short interest and how to trade them. Click the link below to see which companies made the list.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
